• Home
  • Contact Us
  • Try it!
  • Blog
  • Vizit Graphs

Follow us

Recent Posts

  • Biovista in World’s Top 20 AI Drug Development Companies March 22, 2019
  • Biovista signs EU-IMI2 research agreement to advance neurotoxicity de-risking in preclinical drug discovery March 15, 2019
  • The increasing importance of predicting AEs & the role of Augmented Intelligence September 10, 2018
  • New Vizit Bibliography pane January 8, 2018
  • Share to Weibo added to Biovista Vizit October 25, 2017

Biovista Vizit

Biovista Vizit

  • Try it!
  • Blog
  • Vizit Graphs

ABATACEPT

Immune checkpoint blockade in cancer immunotherapy

August 28, 2018Cancer, Cancer Immunotherapy, Vizit Graphs
Immune checkpoint blockade in cancer immunotherapy

Explore immune checkpoint blockade (PD-1, CTLA-4) in cancer immunotherapy with Biovista Vizit. Explore the live graph.

Vizit Graphs Tag Cloud

SOD1 CANCER ERBB-2 CANDIDA ALBICANS IL23A PARKINSON DISEASE AGING STAPHYLOCOCCUS AUREUS ESCHERICHIA COLI HELICOBACTER PYLORI CLOSTRIDIUM DIFFICILE DOXORUBICIN IMMUNE RESPONSE REMICADE IFNG INSULIN INFLAMMATION CTLA4 METFORMIN RECEPTOR APOPTOTIC PROCESS TNF CELL DIVISION CASP3 ANGIOGENESIS RHEUMATOID ARTHRITIS TP53 LISTERIA MONOCYTOGENES CELL PROLIFERATION TH17 CELLS DIABETES MELLITUS PSEUDOMONAS AERUGINOSA IL17A IL6 BREAST CANCER NEURODEGENERATIVE DISORDERS CELL DEATH 1-METHYL-4-PHENYL-1-2-3-6-TETRAHYDROPYRIDINE PORPHYROMONAS GINGIVALIS AUTOPHAGY FOXP3 ALZHEIMER'S DISEASE STREPTOCOCCUS PNEUMONIAE CD4 CELL DIFFERENTIATION

© 2019 Biovista Vizit All Rights Reserved.